17,261 trials
Oral Lichen Planus
Primary: The Primary Efficacy Variable Was the Change in the Investigator's Global Assessment of the Overall Severity of Disease From Baseline to Week 6. — 2.4; 2.45; 1.6; 2.27…
Obsessive-compulsive Disorder
Primary: Children's Yale-Brown Obsessive-Compulsive Scale (CY-BOCS; Scahill et al., 1997). — 26; 24.1; 17.9; 15.6 units on a scale — p=<0.05
Psoriasis Vulgaris
Primary: Change From Baseline in Psoriasis Severity Idex(PSI) at Week 8. — -2.0; -2.1; -1.7; -2.0 units on a scale
Anorexia Nervosa · Osteopenia · Osteoporosis
Primary: Bone Metabolism — 34.3; 10.4 ng/ml
Healthy
Primary: Endothelial Progenitor Cells — 0.101; 0.081 percentage of all lymphocytes — p=0.28
Lung Neoplasms · Ovarian Neoplasms · Cervix Neoplasms
Primary: Geometric Mean of Maximum Concentration of the Drug (Cmax) — 1315; 1093; 1060; 1026 Cmax (ng/mL)
Chronic Lymphocytic Leukemia
Primary: Overall Objective Response — 3 participants who responded
Scar Prevention · Scar Reduction
Primary: Differences Among the 3 Dosage Groups in the Patient (PSAS) and Observer (OSAS) Scar Assessment Scale (POSAS) Scores — 23.29; 24.11; 21.33; 18.53 Units on a scale — p=0.87
Scar Prevention · Scar Reduction
Primary: Differences Among the 3 Dosage Groups in the Patient (PSAS) and Observer (OSAS) Scar Assessment Scale (POSAS) Scores — 8.0; 8.0; 8.3; 6.8 Units on a scale — p=0.57
Scar Prevention · Scar Reduction
Primary: Differences Among the 3 Dosage Groups in the Patient (PSAS) and Observer (OSAS) Scar Assessment Scale (POSAS) Scores — 13.3; 17.7; 15.9; 17.1 Units on a scale — p=0.078
Breast Neoplasm
Primary: Best Overall Response (BOR) — 20.0; 10.3 percentage of participants — p=0.1109
Herpes Zoster · HIV Infections
Primary: Number of Participants With Composite Safety Endpoint of the Occurrence of Serious Adverse Events (SAEs) or Division of AIDS (DAIDS) Grade 3 and 4 Signs and Symptoms…
Chemotherapy-Induced Nausea and Vomiting · Ovarian Cancer
Primary: Efficacy of the Aprepitant/Ramosetron/Dexamethasone Regimen in Terms of the Proportion of Patients With a Complete Response (CR) During the 120 Hour Following Initiation…
Anterior Uveitis · Uveitis
Primary: Change in Excess Central Macular Thickening in the Study Eye, as Measured by Optical Coherence Tomography (OCT), at Week One Compared to Baseline — -38.60 µm
Acute Respiratory Infection
Primary: Percent of Inhaled Radioactive Tracer Particles Cleared From Lungs — 21.4; 23.1 Percentage of inhaled radioactive tracer